Background
Background Diabetes is more Diabetes is more common in people with schizophrenia common in people with schizophrenia than in the general population. than in the general population.
Aims
Aims To explore the possible reasons To explore the possible reasons for the association between diabetes and for the association between diabetes and schizophrenia. schizophrenia.
Method Method Diet and other lifestyle factors
Diet and otherlifestyle factors in patients with schizophrenia were in patients with schizophrenia were reviewed as risk factors for diabetes. reviewed as risk factors for diabetes.
Results
Results People with schizophrenia People with schizophrenia show features of the metabolic syndrome show features of the metabolic syndrome atthe onset of illness, before treatment. atthe onset of illness, before treatment. They also eat a poor diet, take little They also eat a poor diet, take little exercise and have high rates of smoking. exercise and have high rates of smoking. Food intake may be increased further by Food intake may be increased further by antipsychotic medication.Nutritional antipsychotic medication.Nutritional factors appear to have a key role in the factors appear to have a key role in the development of diabetes in patients with development of diabetes in patients with schizophrenia and may also affectthe schizophrenia and may also affectthe outcome and severity of schizophrenia. A outcome and severity of schizophrenia. A common pathway through which diet common pathway through which diet might contribute to the development of might contribute to the development of both diabetes and schizophrenia is both diabetes and schizophrenia is proposed. proposed.
Conclusions Conclusions Lifestyle factors may
Lifestyle factors may influence outcomes in both diabetes and influence outcomes in both diabetes and schizophrenia.Lifestyle interventions are schizophrenia.Lifestyle interventions are the key to improving the long-term health the key to improving the long-term health of people with schizophrenia. of people with schizophrenia. It is well recognised that there is an It is well recognised that there is an increased incidence of type 2 diabetes in increased incidence of type 2 diabetes in people with a diagnosis of schizophrenia people with a diagnosis of schizophrenia (Brown (Brown et al et al, 2000) . The evidence suggests , 2000) . The evidence suggests that this is not only due to the effect of that this is not only due to the effect of medication, but is associated independently medication, but is associated independently with the schizophrenic illness itself. Insulin with the schizophrenic illness itself. Insulin resistance was demonstrated in people with resistance was demonstrated in people with schizophrenia even before antipsychotic schizophrenia even before antipsychotic medication was available, and this has medication was available, and this has now been confirmed in drug-naıve patients now been confirmed in drug-naïve patients (Ryan (Ryan et al et al, 2003 . Insulin resistance and type 2 diabetes Insulin resistance and type 2 diabetes are manifestations of the metabolic syn-are manifestations of the metabolic syndrome, which is strongly influenced by diet. drome, which is strongly influenced by diet. The risk of the metabolic syndrome being The risk of the metabolic syndrome being expressed as disease is much reduced by expressed as disease is much reduced by diets that are low in saturated fat, high in diets that are low in saturated fat, high in polyunsaturated fatty acids (especially polyunsaturated fatty acids (especially omega-3), low in glycaemic load, high in omega-3), low in glycaemic load, high in fibre, and contain adequate amounts of fibre, and contain adequate amounts of fresh fruits, vegetables, nuts and pulses fresh fruits, vegetables, nuts and pulses . Dietary factors are also . Dietary factors are also important in reducing the risk of diabetes important in reducing the risk of diabetes and coronary heart disease for people with and coronary heart disease for people with schizophrenia, just as for the rest of society. schizophrenia, just as for the rest of society. However, the possibility that nutritional However, the possibility that nutritional factors might also affect mental health has factors might also affect mental health has been neglected. been neglected. 
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METHOD METHOD
RESULTS
Ecological studies Ecological studies of diet and schizophrenia of diet and schizophrenia
The long-term outcome of schizophrenia is The long-term outcome of schizophrenia is better in developing countries such as India better in developing countries such as India and Nigeria than in developed countries and Nigeria than in developed countries such as the UK and USA (Hopper & such as the UK and USA (Hopper & Wanderling, 2000) . At first sight this is Wanderling, 2000) . At first sight this is counterintuitive, since Western developed counterintuitive, since Western developed nations have superior medical resources. nations have superior medical resources. As yet unidentified social factors have been As yet unidentified social factors have been postulated to account for this. Diet is postulated to account for this. Diet is largely determined by social, cultural and largely determined by social, cultural and political factors and is therefore pertinent political factors and is therefore pertinent to investigate in this context. It is notable to investigate in this context. It is notable that the pattern of a better outcome of that the pattern of a better outcome of schizophrenia in developing countries schizophrenia in developing countries mirrors the pattern shown by diseases of mirrors the pattern shown by diseases of the metabolic syndrome, which are also less the metabolic syndrome, which are also less common in developing countries than in common in developing countries than in developed nations (Tucker & Buranapin, developed nations (Tucker & Buranapin, 2001 ). 2001 .
Two ecological studies of diet in Two ecological studies of diet in relation to schizophrenia have now been relation to schizophrenia have now been completed. These have investigated the completed. These have investigated the association between schizophrenia out-association between schizophrenia outcomes and diet, using data from World comes and diet, using data from World Health Organization (WHO) reports Health Organization (WHO) reports (World Health Organization, 1979; (World Health Organization, 1979; Jablensky Jablensky et al et al, 1992) and national dietary , 1992) and national dietary data published annually by the Food and data published annually by the Food and Agriculture Organization of the United Agriculture Organization of the United Nations (Food and Agriculture Organiza-Nations (Food and Agriculture Organization, 2003) . The first of these studies tion, 2003). The first of these studies (Christensen & Christensen, 1988) showed (Christensen & Christensen, 1988) showed that a poor outcome of schizophrenia was that a poor outcome of schizophrenia was associated with a high ratio of saturated associated with a high ratio of saturated fatty acid to polyunsaturated fatty acids fatty acid to polyunsaturated fatty acids (PUFA) in the national diet. A subsequent (PUFA) in the national diet. A subsequent ecological analysis, which looked at all ecological analysis, which looked at all individual foodstuffs rather than specific individual foodstuffs rather than specific nutrients, found that refined sugar con-nutrients, found that refined sugar consumption was a robust and independent sumption was a robust and independent predictor of poor outcome of schizophrenia predictor of poor outcome of schizophrenia (Peet, 2004) . Although associations of this (Peet, 2004) . Although associations of this nature cannot be assumed to be causal, nature cannot be assumed to be causal, these findings nevertheless allow the these findings nevertheless allow the hypothesis that a diet high in saturated hypothesis that a diet high in saturated fat, low in polyunsaturated fat and high in fat, low in polyunsaturated fat and high in sugar is detrimental to the outcome of sugar is detrimental to the outcome of schizophrenia. schizophrenia.
Diet of people with schizophrenia Diet of people with schizophrenia
The diet of the general public falls far short The diet of the general public falls far short of the WHO recommendations for a of the WHO recommendations for a healthy diet (World Health Organization, healthy diet (World Health Organization, 2003) . Young people -who are at the age 2003). Young people -who are at the age of greatest risk for schizophrenia -have a of greatest risk for schizophrenia -have a particularly poor diet, consuming large particularly poor diet, consuming large quantities of burgers, fries and full-sugar quantities of burgers, fries and full-sugar carbonated drinks (Henderson carbonated drinks (Henderson et al et al, , 2002) . Studies have suggested that people 2002). Studies have suggested that people with schizophrenia have an even worse diet with schizophrenia have an even worse diet than the general population. McCreadie than the general population. McCreadie et al et al (1998) found that patients with (1998) found that patients with (1999) found that patients with schizophrenia con-found that patients with schizophrenia consumed significantly less fibre and more fat sumed significantly less fibre and more fat than a matched control group. Ryan than a matched control group. Ryan et al et al (2003) reported that drug-naıve patients (2003) reported that drug-naïve patients with first-episode schizophrenia consumed with first-episode schizophrenia consumed substantially more saturated fat than care-substantially more saturated fat than carefully matched, healthy comparison individ-fully matched, healthy comparison individuals. Another recent study (Stokes, 2003) uals. Another recent study (Stokes, 2003) found that sugar consumption was high found that sugar consumption was high among a group of schizophrenia patients, among a group of schizophrenia patients, and that most of this was due to excessive and that most of this was due to excessive sugar sugar consumption by patients with consumption by patients with treatment-treatment-resistant disease taking cloza-resistant disease taking clozapine. It is not clear whether the increased pine. It is not clear whether the increased sugar intake found in this study was related sugar intake found in this study was related to treatment resistance or to clozapine to treatment resistance or to clozapine treatment. treatment.
There is substantial evidence that There is substantial evidence that schizophrenia is associated with abnormal-schizophrenia is associated with abnormalities of phospholipid metabolism and cell ities of phospholipid metabolism and cell membrane PUFA levels (Peet, 2002) . Two membrane PUFA levels (Peet, 2002) . Two studies have shown that levels of PUFA in studies have shown that levels of PUFA in the normal daily diet correlate with the the normal daily diet correlate with the severity of schizophrenia symptoms. Mellor severity of schizophrenia symptoms. showed significant negative (1996) showed significant negative correlations between dietary intake of correlations between dietary intake of omega-3 fatty acids and symptoms of omega-3 fatty acids and symptoms of schizophrenia and of tardive dyskinesia. In schizophrenia and of tardive dyskinesia. In a separate study, Stokes (2003) found that a separate study, Stokes (2003) found that total PUFA in the normal daily diet total PUFA in the normal daily diet correlated negatively with severity of correlated negatively with severity of schizophrenia symptoms and that this was schizophrenia symptoms and that this was independent of the dietary intake of other independent of the dietary intake of other nutrients. nutrients.
In summary, people with schizophrenia In summary, people with schizophrenia consume the type of diet that is known to consume the type of diet that is known to promote diseases of the metabolic promote diseases of the metabolic syndrome (i.e. high in saturated fat, low syndrome (i.e. high in saturated fat, low in fibre, with a high glycaemic load). in fibre, with a high glycaemic load). Furthermore, there is emerging evidence of Furthermore, there is emerging evidence of an association between dietary factors and an association between dietary factors and the severity and long-term outcome of the severity and long-term outcome of schizophrenia. schizophrenia.
Other lifestyle issues Other lifestyle issues
A low level of exercise and the number of A low level of exercise and the number of pack-years of cigarettes smoked are both pack-years of cigarettes smoked are both independent predictors of the central meta-independent predictors of the central metabolic syndrome (Parker bolic syndrome (Parker et al et al, 2003) . People , 2003) . People who have a sedentary lifestyle, parti-who have a sedentary lifestyle, participating in no vigorous physical activity cipating in no vigorous physical activity and watching more than 4 h of television and watching more than 4 h of television a day, are more prone to obesity and cardio-a day, are more prone to obesity and cardiovascular disease risk factors (Jakes vascular disease risk factors (Jakes et al et al, , 2003) . Smoking has been proposed as an 2003). Smoking has been proposed as an independent risk factor for the development independent risk factor for the development of diabetes (Rimm of diabetes (Rimm et al et al, 1995) . , 1995). Lack of exercise and high levels of Lack of exercise and high levels of smoking are also typical of people with smoking are also typical of people with schizophrenia. It has been suggested that schizophrenia. It has been suggested that the sedative effect of antipsychotic medi-the sedative effect of antipsychotic medication might contribute to the sedentary cation might contribute to the sedentary lifestyle of patients with schizophrenia, lifestyle of patients with schizophrenia, although a study of adolescents with although a study of adolescents with schizophrenia showed that daily energy schizophrenia showed that daily energy expenditure was very low even before expenditure was very low even before treatment with antipsychotic agents treatment with antipsychotic agents (Gothelf (Gothelf et al et al, 2002) . Smoking is much , 2002). Smoking is much more prevalent among patients with more prevalent among patients with schizophrenia than in the general popu-schizophrenia than in the general population, and Kelly & McCreadie (1999) lation, and Kelly & McCreadie (1999) found that in 90% of cases the smoking found that in 90% of cases the smoking preceded the onset of schizophrenia. preceded the onset of schizophrenia.
Nicotine can lead to temporary Nicotine can lead to temporary improvement in cognitive function, which improvement in cognitive function, which may explain why people with schizophrenia may explain why people with schizophrenia like to smoke . like to smoke . Kelly & McCreadie (1999) suggested that Kelly & McCreadie (1999) suggested that smoking may be associated with the neuro-smoking may be associated with the neurodevelopmental form of schizophrenia, as it developmental form of schizophrenia, as it occurs more frequently in patients with occurs more frequently in patients with poor premorbid childhood adjustment poor premorbid childhood adjustment (Kelly & McCreadie, 1999) 
Effects of antipsychotic medication Effects of antipsychotic medication on food intake on food intake
Antipsychotic medication can cause people Antipsychotic medication can cause people to eat more (Briffa & Meehan, 1998;  to eat more (Briffa & Meehan, 1998; Gothelf Gothelf et al et al, 2002) . People with , 2002) . People with schizophrenia make poor dietary choices, schizophrenia make poor dietary choices, so that any increase in appetite is likely to so that any increase in appetite is likely to lead to an increased intake of snack and lead to an increased intake of snack and convenience foods, which are high in fat convenience foods, which are high in fat and sugar. Increased food intake leading and sugar. Increased food intake leading to obesity was recognised in the early days to obesity was recognised in the early days of treatment with chlorpromazine and depot of treatment with chlorpromazine and depot antipsychotic medications (Silverstone antipsychotic medications (Silverstone et al et al, , 1988) , and the problem of weight gain and 1988), and the problem of weight gain and diabetes has been highlighted in relation to diabetes has been highlighted in relation to atypical antipsychotic medication (Sernyak atypical antipsychotic medication (Sernyak et al et al, 2002) . However, an increase in , 2002). However, an increase in obesity in the population of people with obesity in the population of people with schizophrenia must be assessed against a schizophrenia must be assessed against a background increase of obesity in the background increase of obesity in the general population (Homel general population (Homel et al et al, 2002) . , 2002). The mechanism by which antipsychotic The mechanism by which antipsychotic medications increase food intake is prob-medications increase food intake is probably related to their effect upon dopamine ably related to their effect upon dopamine and serotonin receptors (Kaur & Kulkarni, and serotonin receptors (Kaur & Kulkarni, 2003) . Increased levels of circulating leptin 2003). Increased levels of circulating leptin have been found after treatment with both have been found after treatment with both conventional and atypical antipsychotic conventional and atypical antipsychotic agents (Hagg agents (Hagg et al et al, 2001) . Leptin is , 2001). Leptin is produced by adipose cells and acts on the produced by adipose cells and acts on the hypothalamus to reduce appetite. Obese hypothalamus to reduce appetite. Obese people are often resistant to this effect of people are often resistant to this effect of leptin (Zabeau leptin (Zabeau et al et al, 2003) , but there is , 2003), but there is no good evidence to suggest that anti-no good evidence to suggest that antipsychotic medications have a primary effect psychotic medications have a primary effect on leptin resistance. Neither do they have a on leptin resistance. Neither do they have a primary effect on pancreatic primary effect on pancreatic b b-cell function -cell function (Sowell (Sowell et al et al, 2002) . Thus, it appears that , 2002). Thus, it appears that glucose dysregulation following anti-glucose dysregulation following antipsychotic treatment might be due to an psychotic treatment might be due to an increased dietary intake of unhealthy increased dietary intake of unhealthy food, rather than a direct effect of the food, rather than a direct effect of the antipsychotic drug on glucose regulation. antipsychotic drug on glucose regulation.
Diet, diabetes and schizophrenia: Diet, diabetes and schizophrenia: a hypothesis a hypothesis Insulin resistance results from an interplay Insulin resistance results from an interplay of genetic and lifestyle factors (Ukkola & of genetic and lifestyle factors (Ukkola & Bouchard, 2001) . Insulin resistance is not Bouchard, 2001) . Insulin resistance is not in itself necessarily harmful and indeed in itself necessarily harmful and indeed may confer an evolutionary advantage may confer an evolutionary advantage (Colagiuri & Miller, 2002) . Australian (Colagiuri & Miller, 2002) . Australian aboriginals show evidence of increased aboriginals show evidence of increased insulin resistance but this does not manifest insulin resistance but this does not manifest itself as pathological until they give up their itself as pathological until they give up their traditional lifestyle and adopt Western traditional lifestyle and adopt Western dietary practices (O'Dea, 1991) . People dietary practices (O'Dea, 1991) . People with schizophrenia who exhibit insulin with schizophrenia who exhibit insulin resistance at the start of their illness will resistance at the start of their illness will therefore have an increased susceptibility therefore have an increased susceptibility to the adverse effects of a poor diet. to the adverse effects of a poor diet.
The most parsimonious explanation for The most parsimonious explanation for the increased prevalence of diabetes in the increased prevalence of diabetes in patients with schizophrenia is that a genetic patients with schizophrenia is that a genetic predisposition to insulin resistance is predisposition to insulin resistance is compounded by an unhealthy lifestyle and compounded by an unhealthy lifestyle and the effect of antipsychotic medication on the effect of antipsychotic medication on food intake. The genetic influence is food intake. The genetic influence is suggested by the increased frequency of suggested by the increased frequency of diabetes in the relatives of patients with diabetes in the relatives of patients with schizophrenia (Mukherjee schizophrenia (Mukherjee et al et al, 1989) . , 1989). However, evidence of a significant asso-However, evidence of a significant association between diet and the outcome and ciation between diet and the outcome and severity of schizophrenia raises the poss-severity of schizophrenia raises the possibility that both diabetes and schizophrenia ibility that both diabetes and schizophrenia share a common pathology which is influ-share a common pathology which is influenced by lifestyle factors such as diet and enced by lifestyle factors such as diet and exercise. One physiological factor that exercise. One physiological factor that could partly explain the link between could partly explain the link between diabetes, schizophrenia and diet is brain-diabetes, schizophrenia and diet is brainderived neurotrophic factor (BDNF). This derived neurotrophic factor (BDNF). This protein is required to maintain dendrites protein is required to maintain dendrites (Gorski (Gorski et al et al, 2003) , and its expression in , 2003), and its expression in the prefrontal cortex shows a significant the prefrontal cortex shows a significant s1 0 3 s1 0 3 P E E T P E E T increase during young adulthood at a time increase during young adulthood at a time when the frontal cortex matures both when the frontal cortex matures both structurally and functionally (Webster structurally and functionally (Webster et al et al, 2002) . The peak requirement for , 2002). The peak requirement for BDNF to preserve dendritic outgrowth thus BDNF to preserve dendritic outgrowth thus occurs at the time of life when schizo-occurs at the time of life when schizophrenia has its peak age of onset. Apart phrenia has its peak age of onset. Apart from influences on neuronal architecture, from influences on neuronal architecture, BDNF is also a neurotransmitter modulator BDNF is also a neurotransmitter modulator and facilitates long-term potentiation in the and facilitates long-term potentiation in the hippocampus (Lessman hippocampus (Lessman et al et al, 2003) . It has , 2003). It has recently been shown that BDNF expression recently been shown that BDNF expression is reduced in the prefrontal cortex of is reduced in the prefrontal cortex of patients with schizophrenia, and it was patients with schizophrenia, and it was suggested that this might be a central , 2002) . Brain-derived neurotrophic factor is also involved in the trophic factor is also involved in the control of insulin resistance. Heterozygous control of insulin resistance. Heterozygous BDNF knockout mice show a 50% reduc-BDNF knockout mice show a 50% reduction in brain levels of BDNF, and they also tion in brain levels of BDNF, and they also show hyperphagia and features of the meta-show hyperphagia and features of the metabolic syndrome (Duan bolic syndrome (Duan et al et al, 2003) . Admin-, 2003) . Administration of BDNF into the cerebral istration of BDNF into the cerebral ventricles of obese/diabetic rodent models ventricles of obese/diabetic rodent models reduces obesity and improves glucose toler-reduces obesity and improves glucose tolerance (Nakagawa ance (Nakagawa et al et al, 2000) , suggesting , 2000), suggesting that the effect of BDNF on the metabolic that the effect of BDNF on the metabolic syndrome is centrally mediated. syndrome is centrally mediated.
On the basis of the findings discussed so On the basis of the findings discussed so far, it is possible to construct a hypothesis far, it is possible to construct a hypothesis whereby the high-fat, high-sugar diet of whereby the high-fat, high-sugar diet of patients with schizophrenia leads to patients with schizophrenia leads to reduced expression of BDNF in the brain. reduced expression of BDNF in the brain. This would exacerbate any genetically This would exacerbate any genetically determined abnormalities of BDNF expres-determined abnormalities of BDNF expression. Although very speculative, this sion. Although very speculative, this provides a possible explanatory model for provides a possible explanatory model for the observed epidemiological association the observed epidemiological association between a high-fat, high-sugar diet and between a high-fat, high-sugar diet and poor long-term outcome of schizophrenia. poor long-term outcome of schizophrenia. Such a diet would also lead to an increased Such a diet would also lead to an increased risk of diabetes, through both peripheral risk of diabetes, through both peripheral and central mechanisms. and central mechanisms.
There is evidence that typical and There is evidence that typical and atypical antipsychotic medications have atypical antipsychotic medications have differential effects upon BDNF. Haloperi-differential effects upon BDNF. Haloperidol has been found to reduce hippocampal dol has been found to reduce hippocampal expression of BDNF, whereas BDNF expression of BDNF, whereas BDNF expression is increased by olanzapine and expression is increased by olanzapine and clozapine (Bai clozapine (Bai et al et al, 2003) . However, since , 2003). However, since there is no clear correlation between these there is no clear correlation between these effects and the efficacy and side-effect effects and the efficacy and side-effect profiles of these drugs, at least in the short profiles of these drugs, at least in the short term, it is unlikely that these agents are term, it is unlikely that these agents are acting through an effect on BDNF. acting through an effect on BDNF.
DISCUSSION DISCUSSION
Clinical importance of lifestyle Clinical importance of lifestyle interventions in schizophrenia interventions in schizophrenia
In order to reduce the risk of obesity, In order to reduce the risk of obesity, diabetes and coronary heart disease in diabetes and coronary heart disease in people with schizophrenia, the importance people with schizophrenia, the importance of a healthy lifestyle -including good of a healthy lifestyle -including good dietary practices and sufficient exercise -dietary practices and sufficient exercisecannot be overemphasised. Because insulin cannot be overemphasised. Because insulin resistance is a feature associated with resistance is a feature associated with schizophrenia independently of any specific schizophrenia independently of any specific drug treatment, lifestyle advice should be drug treatment, lifestyle advice should be given to all patients with a diagnosis of given to all patients with a diagnosis of schizophrenia. This should start immedi-schizophrenia. This should start immediately as part of the package of care at the ately as part of the package of care at the first onset of illness. first onset of illness.
The evidence presented allows the The evidence presented allows the hypothesis that a diet low in saturated fat, hypothesis that a diet low in saturated fat, high in polyunsaturated fatty acids and high in polyunsaturated fatty acids and low in glycaemic load might be beneficial low in glycaemic load might be beneficial also in alleviating the symptoms of schizo-also in alleviating the symptoms of schizophrenia. There are five placebo-controlled phrenia. There are five placebo-controlled trials of omega-3 fatty acids in the treat-trials of omega-3 fatty acids in the treatment of schizophrenia, of which three ment of schizophrenia, of which three showed significant benefit, one showed showed significant benefit, one showed benefit of omega-3 fatty acids only in a benefit of omega-3 fatty acids only in a subgroup of patients already receiving subgroup of patients already receiving treatment with clozapine, and one showed treatment with clozapine, and one showed no advantage of omega-3 fatty acids over no advantage of omega-3 fatty acids over placebo (Peet, 2004) . The proposition that placebo (Peet, 2004) . The proposition that the symptoms and the outcome of schizo-the symptoms and the outcome of schizophrenia might be improved by a diet low phrenia might be improved by a diet low in saturated fat and low in sugar has not in saturated fat and low in sugar has not been systematically investigated, although been systematically investigated, although there are anecdotal reports of the successful there are anecdotal reports of the successful use of this approach . use of this approach .
Unfortunately, there is a dearth of Unfortunately, there is a dearth of evidence concerning the best way to achieve evidence concerning the best way to achieve lifestyle changes in patients with schizo-lifestyle changes in patients with schizophrenia. Werneke phrenia. Werneke et al et al (2003 Werneke et al et al ( ) reviewed (2003 reviewed all studies assessing the behavioural man-all studies assessing the behavioural management of antipsychotic-induced weight agement of antipsychotic-induced weight gain, including both dietary and exercise gain, including both dietary and exercise interventions. They found that current interventions. They found that current studies were methodologically flawed, with studies were methodologically flawed, with none meeting the criteria for a randomised none meeting the criteria for a randomised controlled trial. Approaches aimed at the controlled trial. Approaches aimed at the management of obesity in the general management of obesity in the general population (Glenny population (Glenny et al et al, 1997) are not , 1997) are not necessarily transferable to people with necessarily transferable to people with schizophrenia. schizophrenia.
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